Skip to main content

Biosyent Inc(RX-X)
TSX Venture

Today's Change
Delayed Last Update

Closing Bell: Biosyent Inc flat on Thursday (RX)

Automated Summaries - The Globe and Mail - Thu May 2, 4:01PM CDT

In market activity today, shares of Biosyent Inc opened at $8.60 and closed at $8.69. Intraday prices ranged from $8.60 to $8.69.

The price $verbed percentage_change percent from the previous day's close of $8.69.

During the day across North America, the TSX Composite closed 0.06% at 21728.55, the S&P 500 closed -0.34% at 5018.39, the Dow Jones Industrial Average closed 0.23% at 37903.29 and the Nasdaq Composite closed -0.33% at 15605.48.

Biosyent Inc traded under RX on the Toronto Venture Exchange (TSX-V).

Trading volume was 3,000 on 6 total trades, with an average volume of 4,791 in the last five days.

The TSX-V market on the whole today saw 3,697 price advancers against 1,526 declines and 95 unchanged.

During the prior 52 weeks, RX.VN has traded as high as $9.26 (December 29,2023) and low as $7.03 (July 06,2023). Moreover, in the last 52 weeks, Biosyent Inc's shares have boosted 13.15 percent, while in 2024, they have dipped -5.75%.

It announced a 0.04 dividend on February 07/24, with an February 28/24 ex-date and March 15/24 pay day.

Following today's trading, Biosyent Inc has a market capitalization of $100.85 million on a float of 11,605 shares outstanding. Its annual EPS is $0.53.

Biosyent Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.

Biosyent Inc is holding an average recommendation of "Moderate Buy" from 1.00 analysts according to Zacks. From those 1 analysts, 1 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe